cepharanthine has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Hirano, T; Onda, K; Sugiyama, K; Tanaka, S; Wang, X; Xu, W; Yamada, H | 1 |
| Hirano, T; Masaki, H; Onda, K; Sugiyama, K; Tanaka, S; Tu, Y; Wang, X; Xu, W; Yamada, H | 1 |
1 review(s) available for cepharanthine and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autoimmune Diseases; Benzylisoquinolines; Cell Cycle; Down-Regulation; Drug Therapy, Combination; Glucocorticoids; Humans; Mitogen-Activated Protein Kinases; NF-kappa B; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; T-Lymphocytes; TOR Serine-Threonine Kinases | 2021 |
1 other study(ies) available for cepharanthine and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells.
Topics: Apoptosis; Benzylisoquinolines; Caspases; Cell Cycle Checkpoints; Gene Expression Regulation; Glucocorticoids; Humans; Jurkat Cells; MAP Kinase Signaling System; Phosphatidylinositol 3-Kinases; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |